STOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its inaugural syndicated credit facility. The new aggregate $980 ...
MIDLAND, Pa., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) ("Mawson” or the "Company”) announced today that it has filed an adversary proceeding in the United ...
MIDLAND, Pa., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) ("Mawson” or the "Company”), a U.S. based technology company that designs, builds, and operates ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ ...
Aranan Tarih Aralığı: 2025-12-1 / 2026-01-01 Aranan Kelime: question watch video show examples given the functions f of x equals 5 x to the power 5f x 5x 5 and g of x equals 6 to the power xg x 6 x ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company’s First ...
Lamb Weston Holdings, Inc. (NYSE: LW) announced today its results for the second quarter of fiscal 2026 and updated its full year financial targets for fiscal 2026. Summary of Second Quarter FY 2026 ...
“This is a historic moment for our company and for the patients we serve, as we fulfill our promise to translate our science into medicines that may make a meaningful difference in patients’ lives,” ...
GLENVILLE, N.Y., Dec. 19, 2025 (GLOBE NEWSWIRE) -- TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) (the “Company” or “TrustCo”) today announced that its Board of Directors has approved a new stock ...
Brian Walshe, the Massachusetts man convicted of killing his wife Ana Walshe on New Year's Day 2023 in their Cohasset home, was formally sentenced today to life in prison without the possibility of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback